Citadel Advisors’s Milestone Scientific MLSS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-167,135
| Closed | -$48.1K | – | 14424 |
|
|
2026
Q1 | $48.1K | Buy |
167,135
+13,360
| +9% | +$3.73K | ﹤0.01% | 12417 |
|
|
2025
Q4 | $42K | Buy |
+153,775
| New | +$58.5K | ﹤0.01% | 12117 |
|
|
2025
Q3 | – | Sell |
-39,642
| Closed | -$25.2K | – | 13598 |
|
|
2025
Q2 | $25.2K | Buy |
+39,642
| New | +$36.4K | ﹤0.01% | 12053 |
|
|
2025
Q1 | – | Sell |
-62,438
| Closed | -$68.5K | – | 15171 |
|
|
2024
Q4 | $59.9K | Buy |
62,438
+39,274
| +170% | +$32.4K | ﹤0.01% | 12181 |
|
|
2024
Q3 | $21.1K | Sell |
23,164
-31,169
| -57% | -$29.2K | ﹤0.01% | 12737 |
|
|
2024
Q2 | $37.1K | Buy |
54,333
+14,286
| +36% | +$9.5K | ﹤0.01% | 12062 |
|
|
2024
Q1 | $24.9K | Sell |
40,047
-8,541
| -18% | -$5.61K | ﹤0.01% | 12850 |
|
|
2023
Q4 | $33.5K | Buy |
48,588
+8,694
| +22% | +$6.93K | ﹤0.01% | 12178 |
|
|
2023
Q3 | $36.7K | Sell |
39,894
-49,848
| -56% | -$52.5K | ﹤0.01% | 12100 |
|
|
2023
Q2 | $78.1K | Buy |
+89,742
| New | +$80.8K | ﹤0.01% | 11271 |
|
|
2023
Q1 | – | Sell |
-73,092
| Closed | -$35.1K | – | 15184 |
|
|
2022
Q4 | $35.1K | Buy |
73,092
+15,781
| +28% | +$10.2K | ﹤0.01% | 12563 |
|
|
2022
Q3 | $45K | Sell |
57,311
-99,111
| -63% | -$96.1K | ﹤0.01% | 11704 |
|
|
2022
Q2 | $143K | Buy |
156,422
+143,473
| +1,108% | +$146K | ﹤0.01% | 11030 |
|
|
2022
Q1 | $20K | Sell |
12,949
-29,303
| -69% | -$42.8K | ﹤0.01% | 13241 |
|
|
2021
Q4 | $87K | Buy |
+42,252
| New | +$92.9K | ﹤0.01% | 12846 |
|
|
2021
Q3 | – | Sell |
-25,326
| Closed | -$62K | – | 14335 |
|
|
2021
Q2 | $62K | Buy |
+25,326
| New | +$61.4K | ﹤0.01% | 13230 |
|
|
2021
Q1 | – | Sell |
-29,535
| Closed | -$63K | – | 13526 |
|
|
2020
Q4 | $63K | Buy |
+29,535
| New | +$52K | ﹤0.01% | 10476 |
|
|
2019
Q2 | – | Sell |
-80,914
| Closed | -$27K | – | 9599 |
|
|
2019
Q1 | $27K | Buy |
80,914
+53,592
| +196% | +$19.7K | ﹤0.01% | 9013 |
|
|
2018
Q4 | $9K | Buy |
27,322
+10,736
| +65% | +$5.75K | ﹤0.01% | 8938 |
|
|
2018
Q3 | $12K | Buy |
+16,586
| New | +$13.2K | ﹤0.01% | 9092 |
|
|
2017
Q2 | – | Sell |
-12,787
| Closed | -$17K | – | 7840 |
|
|
2017
Q1 | $17K | Buy |
+12,787
| New | +$17.9K | ﹤0.01% | 7288 |
|
Other funds holding MLSS
Citadel Advisors's MLSS Position: Q2 2026 in Review
Citadel Advisors sold out of Milestone Scientific (MLSS) in Q2 2026, closing a stake of 167,135 shares — an estimated $48.1K sold.
Citadel Advisors first reported a position in MLSS in Q1 2017 and held it in 21 quarters. The position peaked at $143K in Q2 2022. 29 funds tracked by Wall St. Rank hold MLSS as of Q2 2026.
- Citadel Advisors reported no remaining Milestone Scientific position as of Q2 2026 after selling out during the quarter.
- Citadel Advisors sold 167,135 Milestone Scientific shares in Q2 2026, an estimated $48.1K.
- Citadel Advisors first reported a position in Milestone Scientific in Q1 2017 and held it in 21 quarters.
- Citadel Advisors's Milestone Scientific position peaked at $143K in Q2 2022.
- 29 funds tracked by Wall St. Rank held Milestone Scientific as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.